Last reviewed · How we verify
Triamcinolone Acetonide 40mg
At a glance
| Generic name | Triamcinolone Acetonide 40mg |
|---|---|
| Sponsor | The University of Hong Kong |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Evolution of Post-Stroke Shoulder Pain With a Capsular Pattern With Physiotherapy Alone Versus Coupled With Mild Arthrographic Distension With Cortisone (PHASE4)
- Knee Injections for Obese Patients With Knee Arthritis (PHASE4)
- The Effect of Micro Fragmented Adipose Tissue (MFAT) on Knee Osteoarthritis (PHASE3)
- Combined Microneedling With Either 1% Lactic Acid Solution or Vitamin D3 or Triamcinolone Acetonide in The Treatment of Alopecia Areata (NA)
- Lichen Sclerosus - Treatment With Triamcinolone Acetonide: Injections (Syringe and Needle) x Micro Injections (MMP Technique) (NA)
- Corticosteroid Injection Versus Nerve Block (NA)
- A Study to Evaluate an Intra-Articular Injection of ZILRETTA Versus Triamcinolone Acetonide, Immediate Release in Subjects With Osteoarthritis of the Hip (PHASE2)
- The TRIBECA Study (TRIessence/Byqlovi for Easier CAtaract Surgery) (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Triamcinolone Acetonide 40mg CI brief — competitive landscape report
- Triamcinolone Acetonide 40mg updates RSS · CI watch RSS
- The University of Hong Kong portfolio CI